Mon, 30 Jun 2014 | BUSINESS SALE
Electronics retailer Maplin has been sold by Montague Private Equity to Rutland Partners for £85 million.
Rutland Partners, which owns Pizza Hut UK and Bernard Matthews, is a turnaround specialist. The company says it saw “unlocked potential” in Maplin which, after some difficult years of trading, has started to see business improve over the past two years.
Maplin was bought by Montagu in 2004 and is the UK’s biggest specialist consumer electronics retailer. The South Yorkshire-based company, which was founded in 1972, operates out of more than 200 stores and its revenues stand at around £210 million, up from £100 million when it was bought a decade ago.
Law firm Eversheds has advised Maplin and its management team in relation to its sale. PWC acted as adviser to Montagu during the acquisition.
Nick Morrill, managing director of Rutland, said: “We are delighted to be able to invest in Maplin and recognise the great progress made by management so far in the recovery of the business, but more importantly the potential still to be unlocked.”
Maplin chief executive John Cleland added: “Working with the Montagu team over the last few years has been a very positive experience. They have been highly supportive of management’s plans to reposition Maplin for the future, which has enabled us to deliver on our growth plans.
“The recent investment we have made in our shops, our new web platform, our exciting new product range and our people is really starting to pay off as we have enjoyed very strong like-for-like performance coming through in the first six months of 2014.”
______________________________________________________________________
Related information:
Businesses for sale
Business acquisition funding
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.